| Composition | Sitagliptin 100mg |
|---|---|
| Dosage | TABLET |
| Packing Size | 10×7 |
| Packing | Blister |
SITAPRIME 100 is an oral antidiabetic medication formulated with Sitagliptin 100 mg, a Dipeptidyl Peptidase-4 (DPP-4 inhibitor) that helps control blood sugar levels in patients with type 2 diabetes mellitus.
By enhancing incretin hormone activity, Sitagliptin improves insulin secretion in response to meals and reduces glucagon levels, helping to maintain stable blood glucose levels throughout the day.
This makes SITAPRIME 100 an effective therapy for patients struggling with postprandial hyperglycemia and those requiring monotherapy or combination therapy with other antidiabetic agents.
Each tablet contains:
Sitagliptin 100 mg – DPP-4 inhibitor that regulates blood glucose by increasing insulin release and decreasing glucagon secretion.
Tablet
Oral Antidiabetic / Blood Glucose Regulator
SITAPRIME 100 Tablets are indicated for:
Type 2 diabetes mellitus in adults
Patients inadequately controlled with diet and exercise alone
As monotherapy or in combination with other antidiabetic agents such as Metformin, Sulfonylureas, or Insulin
Managing postprandial hyperglycemia
Sitagliptin inhibits the DPP-4 enzyme, which prolongs the activity of incretin hormones (GLP-1 and GIP).
This results in enhanced insulin secretion in response to meals and reduced glucagon release, leading to improved post-meal and fasting blood glucose control.
Recommended Dose: 100 mg once daily, with or without food, or as prescribed by the physician
Route: Oral
Duration: As per medical guidance, based on glycemic control and patient response
Note: Regular monitoring of blood glucose levels is recommended during therapy.
Controls fasting and postprandial blood sugar levels
Improves glycemic control in type 2 diabetes
Can be used as monotherapy or combination therapy
Low risk of hypoglycemia when used alone
Helps reduce complications associated with hyperglycemia
SITAPRIME 100 is generally well tolerated. Rare or mild side effects may include:
Nasopharyngitis or upper respiratory infection
Headache
Mild gastrointestinal disturbances
Rare cases of hypoglycemia when combined with other antidiabetic drugs
Patients should consult their physician if side effects persist.
Not recommended for type 1 diabetes mellitus or diabetic ketoacidosis
Use with caution in renal impairment; dose adjustment may be required
Monitor for pancreatitis symptoms (abdominal pain, nausea, vomiting)
Inform your doctor about other medications to avoid interactions
Consult your physician before use during pregnancy or lactation
Store below 25°C, in a dry place away from direct sunlight. Keep out of reach of children.
Brand Name: SITAPRIME 100
Composition: Sitagliptin 100 mg
Dosage Form: Tablet
Therapeutic Class: Oral Antidiabetic / DPP-4 Inhibitor
Manufacturer: [Insert Company Name]
Packaging: [Example: 10×10 Tablets / Strip]
Effective DPP-4 inhibitor therapy for type 2 diabetes
Helps maintain stable blood glucose levels
Suitable for monotherapy or combination therapy
Low risk of hypoglycemia when used alone
Manufactured under strict GMP quality standards
SITAPRIME 100 (Sitagliptin 100 mg Tablets) provides effective glycemic control by enhancing insulin secretion and regulating glucagon release. Its once-daily dosing and low risk of hypoglycemia make it an ideal choice for type 2 diabetes patients seeking better postprandial and fasting blood sugar management.
